NIHR Oxford Biomedical Research Centre

Enabling translational research through partnership

MENUMENU
  • About
    • About the NIHR Oxford Biomedical Research Centre
    • Activities during COVID-19
    • Strategic Partnership Board
    • Steering Committee
    • Promoting Equality, Diversity and Inclusion in Research
    • Current Vacancies
    • Contact Us
    • Stay in Touch
  • Research

        • Research Overview
        • Clinical Research Facility
        • Health Economics
        • Ethics in the NIHR Oxford BRC
        • 15 Research Themes

        • Cancer
        • Cardiovascular Medicine
        • Digital Health from Hospital to Home
        • Gene and Cell Therapy
        • Genomic Medicine
        • Imaging
        • Inflammation across Tissues
        • Life-saving Vaccines
        • Metabolic Experimental Medicine
        • Modernising Medical Microbiology and Big Infection Diagnostics
        • Musculoskeletal
        • Preventive Neurology
        • Respiratory Medicine
        • Surgical Innovation, Technology and Evaluation
        • Translational Data Science
  • Patient and Public Involvement
    • For patients and the public
    • For researchers
  • Training Hub
    • Training Hub Overview
    • Clinical Academic Pathway
    • Internships
    • Preparatory Research Fellowships
    • Senior Research Fellowships
    • Research Training Bursaries
    • Doctoral Awards
    • Post-Doctoral Awards
    • Other funding
    • Leadership Training
    • Useful Links
    • Training and Education Resources
    • Upcoming Training Events & Courses
  • Industry
    • Collaborate with Oxford BRC
    • Who Do We Work With?
    • Events
    • Further Information and Additional Resources
    • Contacts for Industry
  • Videos
  • News
  • Events

News Archive

You are here: Home > News > News for COVID-19

COVID-19 News

Prior COVID-19 infection offers protection from re-infection for at least six months

20 November 2020 · Listed under COVID-19, Modernising Medical Microbiology and Big Infection Diagnostics, Translational Data Science

Image link to post

A new study suggests that individuals who have previously had COVID-19 are highly unlikely to contract the illness again, for at least six months following their first infection. The study, done as part of a major collaboration between the University of Oxford and Oxford University Hospitals (OUH) ... READ MORE

Interferon-b trial shows positive results

16 November 2020 · Listed under COVID-19, Respiratory Medicine

Image link to post

A trial of a new inhaled antiviral drug for COVID-19 has shown positive results and the drug is now moving into a larger international phase 3 trial of hospitalised patients, which is to be delivered with support from the NIHR. The new treatment, a protein called interferon beta or SNG001, has ... READ MORE

Possible predictors of COVID-19 severity identified

13 November 2020 · Listed under COVID-19, Partnerships for Health, Wealth and Innovation

Image link to post

A study by researchers at the University of Oxford and Imperial College London have developed a checklist of potential predictors that someone may go on to develop a severe form of COVID-19. The paper, produced as part of the RECAP study, was published in the online open-access journal BMJ ... READ MORE

COVID antibodies wane within months, healthcare workers study shows

5 November 2020 · Listed under COVID-19, Modernising Medical Microbiology and Big Infection Diagnostics, Translational Data Science

Image link to post

Antibodies to COVID-19 fall by half in less than 90 days, and antibody levels peak lower and fall faster in younger adults, an ongoing study of staff at Oxford University Hospitals NHS Foundation Trust has revealed. The findings, published on the pre-print server medRxiv, also showed that ... READ MORE

Minimal risk of catching COVID-19 as a result of endoscopy, study finds

28 October 2020 · Listed under Cancer, COVID-19

More than 6,000 patients who underwent endoscopy at 18 NHS hospitals since the start of pandemic have been tested and none contracted COVID as a result of the procedure, a study involving clinicians from Oxford University Hospitals (OUH) NHS Foundation Trust has found. Clinicians hope the ... READ MORE

Oxford study reveals medium-term impact of COVID-19

19 October 2020 · Listed under COVID-19, Imaging

Image link to post

Initial findings from a study looking at the longer-term impact of COVID-19 have shown that a large proportion of COVID-19 patients discharged from hospital were still experiencing symptoms of breathlessness, fatigue, anxiety and depression two to three months after contracting the virus. The ... READ MORE

Prof Sarah Walker receives OBE

12 October 2020 · Listed under COVID-19, Modernising Medical Microbiology and Big Infection Diagnostics

Image link to post

Professor Sarah Walker, the Oxford BRC’s Co-theme Lead for Antimicrobial Resistance and Modernising Microbiology, is to receive an OBE. Prof Walker, Professor of Medical Statistics and Epidemiology at the University of Oxford’s Nuffield Department of Medicine, was recognised for services to ... READ MORE

Hydroxychloroquine does not benefit hospitalised COVID-19 patients, RECOVERY Trial finds

9 October 2020 · Listed under COVID-19, Translational Data Science

Image link to post

Oxford scientists have confirmed that there is no clinical benefit from using hydroxychloroquine on COVID-19 patients in hospital. The findings were published in the New England Journal of Medicine. Hydroxychloroquine was one of the potential COVID-19 treatments being studied as part of the ... READ MORE

Hospitalised COVID-19 patients ‘younger and healthier than flu patients’

7 October 2020 · Listed under COVID-19, Translational Data Science

Patients hospitalised with COVID-19 were more likely male, younger and - in the US and Spain - had fewer comorbidities and lower medication use than hospitalized influenza patients according to a study published by the Observational Health Data Sciences and Informatics (OHDSI) community. This ... READ MORE

Patients with cirrhosis at increased risk of death from COVID-19, study finds

6 October 2020 · Listed under COVID-19, Inflammation across Tissues

Image link to post

An international study led by researchers at Oxford University Hospitals NHS Foundation Trust has shown that patients with cirrhosis are at increased risk of dying as a result of COVID-19. The study, published in the Journal of Hepatology, found that mortality from COVID-19 was particularly ... READ MORE

New trial on use of anti-TNF drugs to treat Covid-19 in care homes

30 September 2020 · Listed under COVID-19, Musculoskeletal

Image link to post

Researchers at the University of Oxford are starting a new study to explore the effectiveness of a common arthritis drug, adalimumab, as a treatment for patients with COVID-19 in the community, especially care homes. Recent studies of patients with COVID-19 have shown that patients already ... READ MORE

Evaluation of LamPORE rapid Covid-19 tests show high levels of diagnostic sensitivity

25 September 2020 · Listed under COVID-19, Modernising Medical Microbiology and Big Infection Diagnostics

Image link to post

Scientists from the University of Oxford’s Nuffield Department of Medicine have today published their evaluation of LamPORE, a novel diagnostic platform for detecting SARS-CoV-2 RNA. This technology, which combines loop-mediated isothermal amplification with nanopore sequencing, has the ... READ MORE

Oxford assay excels in comparison of SARS-CoV-2 antibody tests

24 September 2020 · Listed under COVID-19, Modernising Medical Microbiology and Big Infection Diagnostics

Image link to post

New research shows that, in a head-to-head comparison of five tests used to detect SARS-CoV-2 antibodies, an assay developed by an academic partnership led by the University of Oxford and one manufactured by Siemens had the most accurate results. The study comparing these ‘immunoassays’ has ... READ MORE

‘Awake proning’ associated with improved COVID-19 clinical outcomes

15 September 2020 · Listed under COVID-19, Respiratory Medicine

A study by Oxford respiratory researchers has found that putting COVID-19 patients in a prone position can lead to improved outcomes. The findings of this retrospective study, supported by the NIHR Oxford Biomedical Research Centre, were published in an article by BMJ Open Respiratory ... READ MORE

RECOVERY Trial to test ‘antibody cocktail’

14 September 2020 · Listed under COVID-19, Translational Data Science

Image link to post

The RECOVERY Trial, the world’s largest randomised trial to find effective COVID-19 treatments, will evaluate the impact of an anti-viral antibody cocktail developed to tackle the virus. The announcement was made on 14 September by Regeneron Pharmaceuticals and the University of Oxford, which ... READ MORE

Persistent immune memory of COVID-19 found in recovered patient T cells

10 September 2020 · Listed under COVID-19, Inflammation across Tissues

Image link to post

Oxford University researchers have found that infection with COVID-19 produces a robust T cell response, including inducing T cell ‘memory’ to potentially fight future infections. The results, published in Nature Immunology, are a joint effort from the Oxford COVID-19 immunology group, led ... READ MORE

Low-dose corticosteroids found to reduce mortality in patients with severe COVID-19

2 September 2020 · Listed under COVID-19, Translational Data Science

Oxford patients, clinicians and researchers have contributed important data to new global research which shows that corticosteroids can significantly improve outcomes for severely ill patients with COVID-19. Four research papers published today in the Journal of the American Medical Association ... READ MORE

Hydroxychloroquine study finds increased cardiovascular risk with azithromycin

24 August 2020 · Listed under COVID-19, Musculoskeletal, Translational Data Science

The combination of hydroxychloroquine (HCQ) and azithromycin (AZM) has been linked to significant cardiovascular risks, including mortality, in the largest safety study ever performed on both HCQ and HCQ+AZM. This network study, led by the Observational Health Data Sciences and Informatics ... READ MORE

Paper outlines management of post-acute COVID-19 in primary care

11 August 2020 · Listed under COVID-19, Partnerships for Health, Wealth and Innovation

Image link to post

A new article published in the BMJ has mapped out what is known and what is still unknown about ‘long COVID’, where patients COVID-19 patients continue to experience symptoms many weeks after contracting the virus. The article, co-authored by the NIHR Oxford BRC’s Theme Lead for Partnerships ... READ MORE

Common heart medication does not increase risk of COVID-19 hospitalisation

10 August 2020 · Listed under Cardiovascular Medicine, COVID-19, Digital Health from Hospital to Home, Translational Data Science

Image link to post

A study by Oxford researchers, supported by the NIHR Oxford Biomedical Research Centre (BRC), found that ACE inhibitors and ARBs – both common treatments for high blood pressure and heart failure – are not generally linked to an increased risk of severe COVID-19 disease or an increased likelihood of ... READ MORE

  • « Previous Page
  • 1
  • …
  • 3
  • 4
  • 5
  • 6
  • 7
  • Next Page »

Other News

News Categories

News by Month

See all news

Subscribe to the Oxford BRC Newsletter

Keep informed about the work of the Oxford BRC by subscribing to our Mailchimp e-newsletter. It is produced several times a year and delivers news and information about upcoming events straight to your inbox.

Subscribe Now

Oxford BRC on Social Media

  • Facebook
  • LinkedIn
  • Twitter
  • YouTube

Feedback

We’d love to hear your feedback. Please contact us at obrcenquiries@ouh.nhs.uk

  • Data Control and Privacy
  • Accessibility
  • Our Partners
  • Disclaimer
  • Contact

Copyright © 2023 NIHR Oxford Biomedical Research Centre